Consolidated net profit of Birla Corporation Limited, the flagship company of M P Birla group, increased 32.7 per cent at Rs 256.60 crore during the fourth quarter of 2024-25 as compared to Rs 193.34 crore in the corresponding previous period.
5 pharma stks with upside potential of up to 12%
Nifty Pharma index has moved in tandem with the headline index, with nearly 5% returns in the last month, with stocks gaining by up to